Literature DB >> 22624878

The role of CD98hc in mouse macrophage functions.

Hideki Tsumura1, Morihiro Ito, Xiao-Kang Li, Akane Nakamura, Naoko Ohnami, Jun-Ichiro Fujimoto, Hiroshi Komada, Yasuhiko Ito.   

Abstract

CD98hc is a type II transmembrane protein that covalently links to one of several L-type amino acid transporters. CD98hc was first identified as a lymphocyte activation marker. In this study, we examined the role that CD98hc plays in the functions of macrophages using tissue specific knock-out miceCD98hc (CD98hc(flox/-)LysM-cre mice). When isolated peritoneal macrophages were incubated for 48 h, the macrophages obtained from the knock-out mice showed round-shaped morphologies, while almost all of the cells obtained from the control mice were spindle-shaped. The macrophage functions such as the antigen-presenting, phagocytic, and fusion activities, have been reported to decrease in CD98hc-deficient peritoneal macrophages. In addition, when the CD98hc deficient macrophages were stimulated with either IFN-γ/LPS or IL-4, the production of NO(2) or arginase-I decreased in comparison to that observed in the control macrophages. These findings show that the CD98hc molecules play an important role in the activation and functions of macrophages.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22624878     DOI: 10.1016/j.cellimm.2012.04.012

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

1.  Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.

Authors:  Hamed Laroui; Duke Geem; Bo Xiao; Emilie Viennois; Poonam Rakhya; Timothy Denning; Didier Merlin
Journal:  Mol Ther       Date:  2013-09-12       Impact factor: 11.454

2.  Agonistic anti-CD148 monoclonal antibody attenuates diabetic nephropathy in mice.

Authors:  Keiko Takahashi; Rachel H Kim; Lejla Pasic; Lilly He; Shinya Nagasaka; Daisuke Katagiri; Tracy May; Akira Shimizu; Raymond C Harris; Raymond L Mernaugh; Takamune Takahashi
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-27

Review 3.  T cell metabolic fitness in antitumor immunity.

Authors:  Peter J Siska; Jeffrey C Rathmell
Journal:  Trends Immunol       Date:  2015-03-12       Impact factor: 16.687

4.  CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis.

Authors:  Joseph M Cantor
Journal:  J Neuroimmunol       Date:  2014-06-26       Impact factor: 3.478

5.  Loss of the branched-chain amino acid transporter CD98hc alters the development of colonic macrophages in mice.

Authors:  Philipp Wuggenig; Berna Kaya; Hassan Melhem; C Korcan Ayata; Petr Hruz; A Emre Sayan; Hideki Tsumura; Morihiro Ito; Julien Roux; Jan Hendrik Niess
Journal:  Commun Biol       Date:  2020-03-18

6.  Conditional deletion of CD98hc inhibits osteoclast development.

Authors:  Hideki Tsumura; Morihiro Ito; Masamichi Takami; Miyuki Arai; Xiao-Kang Li; Toshio Hamatani; Arisa Igarashi; Shuji Takada; Kenji Miyado; Akihiro Umezawa; Yasuhiko Ito
Journal:  Biochem Biophys Rep       Date:  2015-12-02

7.  Host-microbe cross-talk governs amino acid chirality to regulate survival and differentiation of B cells.

Authors:  Masataka Suzuki; Tomohisa Sujino; Sayako Chiba; Yoichi Harada; Motohito Goto; Riichi Takahashi; Masashi Mita; Kenji Hamase; Takanori Kanai; Mamoru Ito; Matthew Kaden Waldor; Masato Yasui; Jumpei Sasabe
Journal:  Sci Adv       Date:  2021-03-03       Impact factor: 14.136

8.  Relationships between Slc1a5 and Osteoclastogenesis.

Authors:  Hideki Tsumura; Miyuki Shindo; Morihiro Ito; Arisa Igarashi; Kazue Takeda; Kenji Matsumoto; Takashi Ohkura; Kenji Miyado; Fumihiro Sugiyama; Akihiro Umezawa; Yasuhiko Ito
Journal:  Comp Med       Date:  2021-06-28       Impact factor: 0.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.